Document Type
Article
Publication Date
7-20-2024
Keywords
andexanet alfa, medication review, anticoagulant reversal agents, hemorrhage, intracranial hemorrhages
Abstract
Medication-use evaluations are meant to ensure that medication-use processes are consistent with prevailing standards of care, assure optimal use of therapy, and reduce the risk of medication-related problems. Reversal agents for direct oral anticoagulants are a worthy focus for medication-use evaluations for reasons of efficacy, safety, and cost. A multidisciplinary team of experts developed 2 medication-use evaluation templates illustrating the application of professional society guidelines to the appropriate use of andexanet alfa.
Publisher Attribution
Journal of Pharmacy Practice 2024, Vol. 0(0) 1–6 © The Author(s) 2024 Article reuse guidelines: sagepub.com/journals-permissions
Recommended Citation
Fera, Toni; Burnett, Allison; Grandoni, Jessica; Moore, Mary R.; Nussbaum, Barbara B.; Pollack, Charles V. Jr.; Rose, Anne E.; Spinler, Sarah A.; Streiff, Michael B.; Turck, Charles J.; and Fanikos, John, "Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors" (2024). Pharmacy Faculty Scholarship. 36.
https://orb.binghamton.edu/pharmacy_fac/36
Comments
10.1177/08971900241263164